SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Feb-24 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Feb-24 | Option Exercise | 1,264 | $56.62 | $71,564.30 | 4% 28.63K to 29.89K | |
29-Feb-24 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 28-Feb-24 | Option Sale | 140 | $88.46 | $12,384.40 | (< 1%) 29.89K to 29.75K | |
29-Feb-24 6:50 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 27-Feb-24 | Grant | 7,208 | -- | -- | 34% 21.42K to 28.63K | |
16-Feb-24 8:10 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-24 | Payment of Exercise | 1,479 | $74.65 | $110,407.00 | (6%) 22.9K to 21.42K | |
06-Dec-23 3:27 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 05-Dec-23 | Payment of Exercise | 1,269 | $59.61 | $75,645.10 | (5%) 24.17K to 22.9K | |
03-Oct-23 4:36 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Oct-23 | Payment of Exercise | 346 | $59.92 | $20,732.30 | (1%) 24.52K to 24.17K | |
10-Jul-23 6:42 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Jun-23 | Acquisition (other) | 375 | $56.78 | $21,292.50 | 2% 24.14K to 24.52K | |
27-Feb-23 8:54 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 23-Feb-23 | Grant | 6,046 | -- | -- | 33% 18.1K to 24.14K | |
17-Feb-23 7:20 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Feb-23 | Payment of Exercise | 849 | $72.98 | $61,960.00 | (4%) 18.95K to 18.1K | |
04-Jan-23 5:00 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Dec-22 | Acquisition (other) | 275 | $56.78 | $15,614.50 | 1% 18.67K to 18.95K | |
15-Dec-22 6:13 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 13-Dec-22 | Grant | 11,000 | -- | -- | 143% 7.67K to 18.67K | |
01-Dec-22 9:41 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 30-Nov-22 | Payment of Exercise | 1,187 | $72.90 | $86,532.30 | (13%) 8.86K to 7.67K | |
10-Nov-22 4:30 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 09-Nov-22 | Sale | 1,696 | $75.64 | $128,283.00 | (16%) 10.55K to 8.86K |